AMF30a通过调节TGF-β/ROCK/HIPPO通路促进人类角膜内皮细胞的生存和功能

Yunkyoung Ryu1,2, Hye-Jin Son1,2, Jin Sun Hwang1,2

  • 1Department of Ophthalmology, Hallym University Medical Center, Hallym University College of Medicine, 1 Shingil-ro, Youngdeungpo-gu, Seoul, 07441, Republic of Korea.

Scientific reports
|August 2, 2025
PubMed
概括

作为PAD2抑制剂的AMF30a增强了角膜内皮细胞的生存和功能. 它保护TGF-β诱导的损伤,建议AMF30a作为角膜内皮细胞疾病的潜在治疗方法.